REG - Mawer Investment Aon PLC - Form 8.3 - Aon plc

AonAnnouncement

04/06/2020 15:55

RNS Number : 0182P
  
Mawer Investment Management Ltd
  
04 June 2020
  
 

Ap19
 
 
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


Mawer Investment Management Ltd. 




Company dealt in


Aon plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.01 ordinary shares
ISIN: IE00BLP1HW54




Date of dealing


03 June 2020




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


5,365,794     (2.32%)*


 




(2) Derivatives (other than options)


 


 




(3) Options and agreements to purchase/sell


 


 




Total


5,365,794     (2.32%)*


 



 
 
 
 
 
 
 



 
(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)




Class of relevant security:


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


 


 




 
(2) Derivatives (other than options)


 


 




 
(3) Options and agreements to purchase/sell


 


 




Total


 


 



 
 
 
 
 
 
 




 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (Note 5)




See Appendix 1


 


 




 


 


 




 


 


 




 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(Note 5)




 


 


 


 




 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 





 

Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 
voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 
or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 
 
 
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            NO
 




Date of disclosure


June 4, 2020




Contact name


Amanda Tesarski




Telephone number


1 416 865 3930




If a connected EFM, name of offeree/offeror with which connected


 




If a connected EFM, state nature of connection (Note 10)


 




*Securityholding percentage calculated based on shares outstanding as of 
  March 9, 2020.
 




Appendix 1: Purchases 




 




Purchase/Sale


Number of relevant securities


Price per unit (USD)




Purchase


118


199.07




Purchase


122


199.08




Purchase


241


199.17




Purchase


127


199.26




Purchase


71


199.28




Purchase


381


199.33




Purchase


639


199.38




Purchase


483


199.44




Purchase


521


199.54




Purchase


439


199.62




Purchase


237


199.66




Purchase


306


199.71




Purchase


128


199.74




Purchase


204


199.75




Purchase


2088


199.76




Purchase


301


199.77




Purchase


405


199.78




Purchase


134


199.79




Purchase


1739


199.8




Purchase


71


199.85




Purchase


241


199.88




Purchase


247


199.89




Purchase


123


199.92




Purchase


100


199.925




Purchase


100


199.93




Purchase


100


200.05




Purchase


34


200.06




Purchase


450


200.07




Purchase


100


200.09




Purchase


200


200.095




Purchase


100


200.11




Purchase


240


200.13




Purchase


200


200.14




Purchase


100


200.15




Purchase


471


200.18




Purchase


200


200.19




Purchase


200


200.195




Purchase


100


200.2




Purchase


400


200.21




Purchase


200


200.215




Purchase


301


200.22




Purchase


210


200.225




Purchase


700


200.23




Purchase


100


200.235




Purchase


500


200.24




Purchase


400


200.25




Purchase


200


200.26




Purchase


821


200.27




Purchase


200


200.275




Purchase


632


200.28




Purchase


100


200.2825




Purchase


390


200.285




Purchase


100


200.2875




Purchase


1195


200.29




Purchase


200


200.2925




Purchase


1900


200.295




Purchase


1722


200.3




Purchase


71


200.335




Purchase


130


200.39




Purchase


13


200.43




Purchase


71


200.53




Purchase


404


200.62




Purchase


234


200.66




Purchase


118


200.92




Purchase


368


200.94




Purchase


124


200.99




Purchase


406


201.05




Purchase


303


201.1




Purchase


110


201.24




Purchase


136


201.32




Purchase


130


201.33




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEFLFESRFISIII